grepcent public filings, reorganized for comparison

PACS Group, Inc. (PACS)

CIK: 0002001184. SIC: 8051 Services-Skilled Nursing Care Facilities. Latest 10-K as of: 2026-02-27.

SIC breadcrumb: Services > SIC Major Group 80 > SIC 8051 Services-Skilled Nursing Care Facilities

SEC company page: https://www.sec.gov/edgar/browse/?CIK=2001184. Latest filing source: 0002001184-26-000005.

Informational only. Descriptive public-record data — not a rating, forecast, or investment advice. See Disclaimer.

At a glance

FY2025 · period end 2025-12-31 · filed 2026-02-27 · accession 0002001184-26-000005 · source: SEC companyfacts

Revenue
5,288,932,000 USD verified
Net income
191,543,000 USD verified
Assets
5,584,034,000 USD verified
Net margin
3.62% computed
Operating margin
5.85% computed
Revenue YoY
+29.32% computed
ROE
20.23% computed

Computed values are grepcent-computed from the verified facts above and may differ from ratios the company itself reports. Net margin = net income ÷ revenue. Operating margin = operating income ÷ revenue. Revenue YoY = FY2025 revenue ÷ FY2024 revenue − 1 (consecutive fiscal years only). ROE = net income ÷ period-end stockholders' equity.

No market price, no rating, no forecast on this site. Not investment advice.

Peer & cluster context

Peer percentile fingerprint

PACS ratios vs SIC peers. Source: grepcent computed from latest SEC companyfacts ratios; peer set SIC major-group 80; per-ratio N printed.PACS ratios vs SIC peers. Source: grepcent computed from latest SEC companyfacts ratios; peer set SIC major-group 80; per-ratio N printed.RatioPACSPeer medianPercentileNNet margin3.6%3.2%5556Operating margin5.9%5.5%5451Revenue growth29.3%11.8%8657ROE20.2%7.9%8353ROA3.4%2.8%5658Liabilities / equity4.891.138754Current ratio1.071.632158

Percentile = share of the N covered peers reporting that ratio whose value is lower (ties counted half); computed among grepcent-covered companies in SIC major-group 80 SIC Major Group 80, not the whole market. A higher percentile means a higher value of the ratio, not a better company. Ratios with fewer than 8 reporting peers are omitted. Latest reported values per company; fiscal periods may differ. Descriptive arithmetic - not a score, rating, or ranking.

Selected Fundamentals

MetricValueUnitFYFiled
Revenue5,288,932,000USD20252026-02-27
Net income191,543,000USD20252026-02-27
Assets5,584,034,000USD20252026-02-27

Financials

Annual standardized facts from SEC companyfacts as of latest extracted filing date 2026-02-27. Source: https://data.sec.gov/api/xbrl/companyfacts/CIK0002001184.json. Derived margins, ratios, and free cash flow are computed from the extracted annual SEC facts.

Download these verified figures (annual + quarterly, with per-value filing provenance): JSON · CSV

Flow metrics use full-year FY periods from 10-K/10-K/A filings; balance-sheet metrics use FY-end instants. Free cash flow = operating cash flow - capital expenditures. Missing metrics are omitted rather than fabricated.

Metric2022202320242025
Revenue2,421,994,0003,111,492,0004,089,734,0005,288,932,000
Net income150,496,000112,874,00055,760,000191,543,000
Operating income229,360,000207,772,000123,073,000309,595,000
Diluted EPS1.170.880.381.22
Operating cash flow92,615,00063,697,000367,341,000404,224,000
Dividends paid60,280,00080,394,00033,721,0000.00
Assets3,512,739,0005,242,909,0005,584,034,000
Liabilities3,411,013,0004,527,218,0004,631,585,000
Stockholders' equity96,126,000709,554,000946,771,000
Cash and cash equivalents58,269,00073,416,000157,674,000197,016,000

Ratios

ROE and ROA use period-end equity/assets. Liabilities / equity uses total liabilities divided by stockholders' equity. Current ratio uses current assets divided by current liabilities when both are reported.

Metric2022202320242025
Net margin6.21%3.63%1.36%3.62%
Operating margin9.47%6.68%3.01%5.85%
Return on equity117.42%7.86%20.23%
Return on assets3.21%1.06%3.43%
Liabilities / equity35.486.384.89
Current ratio1.580.961.07

Industry Peer Context

Each number-line places PACS against the min, median, and max of latest reported values among companies in the same SIC industry when at least three peers report that ratio.

Net margin peer context

PACS Net margin versus SIC peer range. Source: grepcent computed from latest SEC companyfacts ratios for SIC industry 8051; peer count 3.PACS Net margin versus SIC peer range. Source: grepcent computed from latest SEC companyfacts ratios for SIC industry 8051; peer count 3.3 SIC peersMin 3.6%Median 6.8%Max 7.9%PACS 3.6%

Operating margin peer context

PACS Operating margin versus SIC peer range. Source: grepcent computed from latest SEC companyfacts ratios for SIC industry 8051; peer count 3.PACS Operating margin versus SIC peer range. Source: grepcent computed from latest SEC companyfacts ratios for SIC industry 8051; peer count 3.3 SIC peersMin 5.9%Median 8.4%Max 8.5%PACS 5.9%

ROE peer context

PACS ROE versus SIC peer range. Source: grepcent computed from latest SEC companyfacts ratios for SIC industry 8051; peer count 3.PACS ROE versus SIC peer range. Source: grepcent computed from latest SEC companyfacts ratios for SIC industry 8051; peer count 3.3 SIC peersMin 11.2%Median 15.4%Max 20.2%PACS 20.2%

ROA peer context

PACS ROA versus SIC peer range. Source: grepcent computed from latest SEC companyfacts ratios for SIC industry 8051; peer count 3.PACS ROA versus SIC peer range. Source: grepcent computed from latest SEC companyfacts ratios for SIC industry 8051; peer count 3.3 SIC peersMin 3.4%Median 6.3%Max 7.9%PACS 3.4%

Financial Charts

PACS revenue, last 4 periods. Source: SEC companyfacts FY2025.PACS revenue, last 4 periods. Source: SEC companyfacts FY2025.PACS RevenueLatest point: FY2025 = $5.3BSource: SEC companyfacts FY2025.Fiscal yearReported revenue$0.0B$3.0B$6.0B$2.4BFY2022$3.1BFY2023$4.1BFY2024$5.3BFY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0002001184-26-000005; filed 2026-02-27. Concept: Revenues. Source concepts: us-gaap:Revenues.

PACS net income, last 4 periods. Source: SEC companyfacts FY2025.PACS net income, last 4 periods. Source: SEC companyfacts FY2025.PACS Net incomeLatest point: FY2025 = $191.5MSource: SEC companyfacts FY2025.Fiscal yearNet income$0.0B$125.0M$250.0M$150.5MFY2022$112.9MFY2023$55.8MFY2024$191.5MFY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0002001184-26-000005; filed 2026-02-27. Concept: NetIncomeLoss. Source concepts: us-gaap:NetIncomeLoss.

PACS operating income, last 4 periods. Source: SEC companyfacts FY2025.PACS operating income, last 4 periods. Source: SEC companyfacts FY2025.PACS Operating incomeLatest point: FY2025 = $309.6MSource: SEC companyfacts FY2025.Fiscal yearOperating income$0.0B$250.0M$500.0M$229.4MFY2022$207.8MFY2023$123.1MFY2024$309.6MFY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0002001184-26-000005; filed 2026-02-27. Concept: OperatingIncomeLoss. Source concepts: us-gaap:OperatingIncomeLoss.

PACS diluted eps, last 4 periods. Source: SEC companyfacts FY2025.PACS diluted eps, last 4 periods. Source: SEC companyfacts FY2025.PACS Diluted EPSLatest point: FY2025 = $1.22/shareSource: SEC companyfacts FY2025.Fiscal yearDiluted EPS (USD/share)$0.00/share$0.75/share$1.50/shareFY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0002001184-26-000005; filed 2026-02-27. Concept: EarningsPerShareDiluted. Source concepts: us-gaap:EarningsPerShareDiluted.

PACS operating cash flow, last 4 periods. Source: SEC companyfacts FY2025.PACS operating cash flow, last 4 periods. Source: SEC companyfacts FY2025.PACS Operating cash flowLatest point: FY2025 = $404.2MSource: SEC companyfacts FY2025.Fiscal yearOperating cash flow$0.0B$250.0M$500.0M$92.6MFY2022$63.7MFY2023$367.3MFY2024$404.2MFY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0002001184-26-000005; filed 2026-02-27. Concept: NetCashProvidedByUsedInOperatingActivities. Source concepts: us-gaap:NetCashProvidedByUsedInOperatingActivities.

PACS dividends paid, last 4 periods. Source: SEC companyfacts FY2025.PACS dividends paid, last 4 periods. Source: SEC companyfacts FY2025.PACS Dividends paidLatest point: FY2025 = $0.0BSource: SEC companyfacts FY2025.Fiscal yearDividends paid$0.0B$125.0M$250.0MFY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0002001184-26-000005; filed 2026-02-27. Concept: PaymentsOfDividends. Source concepts: us-gaap:PaymentsOfDividends.

PACS assets, last 3 periods. Source: SEC companyfacts FY2025.PACS assets, last 3 periods. Source: SEC companyfacts FY2025.PACS AssetsLatest point: FY2025 = $5.6BSource: SEC companyfacts FY2025.Fiscal yearAssets$0.0B$3.0B$6.0B$3.5BFY2023$5.2BFY2024$5.6BFY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0002001184-26-000005; filed 2026-02-27. Concept: Assets. Source concepts: us-gaap:Assets.

PACS liabilities, last 3 periods. Source: SEC companyfacts FY2025.PACS liabilities, last 3 periods. Source: SEC companyfacts FY2025.PACS LiabilitiesLatest point: FY2025 = $4.6BSource: SEC companyfacts FY2025.Fiscal yearLiabilities$0.0B$3.0B$6.0B$3.4BFY2023$4.5BFY2024$4.6BFY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0002001184-26-000005; filed 2026-02-27. Concept: Liabilities. Source concepts: us-gaap:Liabilities.

PACS stockholders' equity, last 3 periods. Source: SEC companyfacts FY2025.PACS stockholders' equity, last 3 periods. Source: SEC companyfacts FY2025.PACS Stockholders' equityLatest point: FY2025 = $946.8MSource: SEC companyfacts FY2025.Fiscal yearStockholders' equity$0.0B$500.0M$1.0B$96.1MFY2023$709.6MFY2024$946.8MFY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0002001184-26-000005; filed 2026-02-27. Concept: StockholdersEquity. Source concepts: us-gaap:StockholdersEquity.

PACS cash and cash equivalents, last 4 periods. Source: SEC companyfacts FY2025.PACS cash and cash equivalents, last 4 periods. Source: SEC companyfacts FY2025.PACS Cash and cash equivalentsLatest point: FY2025 = $197.0MSource: SEC companyfacts FY2025.Fiscal yearCash and cash equivalents$0.0B$125.0M$250.0M$58.3MFY2022$73.4MFY2023$157.7MFY2024$197.0MFY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0002001184-26-000005; filed 2026-02-27. Concept: CashAndCashEquivalentsAtCarryingValue. Source concepts: us-gaap:CashAndCashEquivalentsAtCarryingValue.

As-reported value updates

No tracked differences above grepcent's stated thresholds and capped precision rule were found between the earliest XBRL-filed value and the value currently on file for the standardized annual metrics grepcent tracks.

Quarterly

Quarterly standardized facts from SEC companyfacts as of latest extracted filing date 2026-08-04. Source: https://data.sec.gov/api/xbrl/companyfacts/CIK0002001184.json.

Flow metrics use discrete quarter-length periods from 10-Q/10-Q/A filings. Q4 revenue and net income are derived only when annual FY and nine-month YTD facts exist for the same fiscal year; derived Q4 values are labeled. EPS Q4 is not derived.

QuarterEnd DateRevenueNet IncomeDiluted EPSMethod
2024-Q12024-03-31934,721,00049,140,0000.38reported discrete quarter
2024-Q22024-06-30981,846,000-10,908,000-0.07reported discrete quarter
2025-Q22025-06-301,309,236,00050,966,0000.31reported discrete quarter
2025-Q32025-09-301,344,567,00052,330,0000.32reported discrete quarter
2025-Q42025-12-311,357,979,00059,785,000derived Q4 = FY annual - nine-month YTD
2026-Q12026-03-311,420,494,00080,668,0000.50reported discrete quarter
2026-Q22026-06-301,427,998,00076,349,0000.47reported discrete quarter

Quarterly Charts

PACS quarterly revenue, last 7 periods. Source: SEC companyfacts 2026-Q2.PACS quarterly revenue, last 7 periods. Source: SEC companyfacts 2026-Q2.PACS Quarterly RevenueLatest point: 2026-Q2 = $1.4BSource: SEC companyfacts 2026-Q2.Fiscal quarterQuarterly Revenue$0.0B$1.0B$2.0B2024-Q12024-Q22025-Q22025-Q32025-Q42026-Q12026-Q2

Figure provenance: SEC companyfacts. Latest point: FY 2026 ended 2026-06-30; accession 0002001184-26-000030; filed 2026-08-04. Concept: Revenues. Source concepts: us-gaap:Revenues.

PACS quarterly net income, last 7 periods. Source: SEC companyfacts 2026-Q2.PACS quarterly net income, last 7 periods. Source: SEC companyfacts 2026-Q2.PACS Quarterly Net incomeLatest point: 2026-Q2 = $76.3MSource: SEC companyfacts 2026-Q2.Fiscal quarterQuarterly Net income-$250.0M$0.0B$250.0M2024-Q12024-Q22025-Q22025-Q32025-Q42026-Q12026-Q2

Figure provenance: SEC companyfacts. Latest point: FY 2026 ended 2026-06-30; accession 0002001184-26-000030; filed 2026-08-04. Concept: ProfitLoss. Source concepts: us-gaap:ProfitLoss.

PACS quarterly diluted eps, last 6 periods. Source: SEC companyfacts 2026-Q2.PACS quarterly diluted eps, last 6 periods. Source: SEC companyfacts 2026-Q2.PACS Quarterly Diluted EPSLatest point: 2026-Q2 = $0.47/shareSource: SEC companyfacts 2026-Q2.Fiscal quarterQuarterly Diluted EPS (USD/share)-$0.50/share$0.00/share$1.00/share2024-Q12024-Q22025-Q22025-Q32026-Q12026-Q2

Figure provenance: SEC companyfacts. Latest point: FY 2026 ended 2026-06-30; accession 0002001184-26-000030; filed 2026-08-04. Concept: EarningsPerShareDiluted. Source concepts: us-gaap:EarningsPerShareDiluted.

Business

Read PACS's verbatim Item 1 Business section from its latest 10-K: Business.

Risk Factors

Read PACS's verbatim Item 1A Risk Factors from its latest 10-K: Risk Factors.

Latest quarter (10-Q)

Latest 10-Q source: 0002001184-26-000030.

Extracted structurally from real Item 2 body heading to real Item 3/4 boundary. Published MD&A gate trimmed front/tail over-capture. Confidence: high. Filing date: 2026-08-04. Report date: 2026-06-30.

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

The following discussion should be read in conjunction with the unaudited condensed consolidated financial statements and accompanying notes, which appear elsewhere in this Quarterly Report on Form 10-Q. We urge you to carefully review and consider the various disclosures made by us in this report and in our other reports filed with the Securities and Exchange Commission (SEC), including our Annual Report on Form 10-K for the year ended December 31, 2025 (Annual Report) which discusses our business and related risks in greater detail, as well as subsequent reports we may file from time to time on Form 10-Q and Form 8-K, for additional information. The sections titled “Risk Factors” contained in this Quarterly Report on Form 10-Q and our Annual Report, and similar discussions in our other SEC filings, also describe some of the important risk factors that may affect our business, financial condition, results of operations and/or liquidity. You should carefully consider those risks, in addition to the other information in this Quarterly Report on Form 10-Q and in our other filings with the SEC, before deciding to purchase, hold or sell our common stock.

Overview

We are a leading post-acute healthcare company primarily focused on delivering high-quality skilled nursing care through a portfolio of independently operated facilities. Founded in 2013, we are one of the largest skilled nursing providers in the United States based on number of facilities. We also provide senior care, assisted living, and independent living options in some of our communities. As of June 30, 2026, our portfolio consisted of 324 post-acute care, assisted living, and independent living facilities across 17 states serving 31,900 patients daily. We believe our significant historical growth has been primarily driven by our expertise in acquiring underperforming long-term custodial care skilled nursing facilities and transforming them into higher acuity, high value-add short-term transitional care skilled nursing facilities. We believe our success is driven in significant part by our locally led, centrally supported operating model, through which we empower local leaders at each facility to operate their facility autonomously and deliver excellence in clinical quality and a superior experience for our patients. We provide our independently operated facilities with a comprehensive suite of technology, support, and back-office services that allow local leadership teams to focus more of their time and effort on providing quality care to patients. We believe our operating model delivers value to all of our healthcare stakeholders, including patients and families, referring providers, payors, and administrators and clinicians.

We aim to create value by identifying and acquiring underperforming and moderately-performing custodial care facilities and converting them into higher-value short-term transitional care facilities by investing in clinical teams and processes and upgrading technology, equipment, training, staffing, aesthetics, and other aspects of the business. We believe the resources and guidance offered by PACS Services is key to rapid integration of new facilities and provides our local leadership teams with an effective technology infrastructure, support tools, and regional support teams that allow local leadership to focus on operational improvements. Our facilities generally undergo an up to three-year post-acquisition transition period. During this period, we seek to implement best practices designed to realize and sustain the facility’s full potential. These practices often result in significant improvements to clinical quality and other operational metrics, including skilled mix, occupancy rates and payor contracting. We believe the results of our acquisition strategy are demonstrated by our high average QM Star rating and occupancy rate for Mature facilities, which we define as facilities purchased greater than 36 months prior to the measurement date, as compared to the same metrics for our New facilities, which we define as facilities purchased less than 18 months prior to the measurement date. As of June 30, 2026, our average QM Star rating and occupancy rate for Mature facilities were 4.5 and 94%, respectively, compared to 4.0 and 79%, respectively for New facilities as of the same date.

Industry Trends

We operate in the post-acute care industry, which is an essential component of the healthcare delivery ecosystem, serving high need, medically fragile patients. The post-acute care industry has evolved to meet the growing demand for post-acute and custodial healthcare services generated by an aging population, increasing life expectancies and the trend toward shifting patient care to lower cost settings. The industry continues to evolve, driven by several trends, including the following:

SNFs are an Integral and Essential Part of the Post-Acute Care Continuum. SNFs play an essential role in post-acute patient care. SNFs provide higher-acuity skilled nursing care to patients that cannot be adequately treated in community-based care settings, such as assisted living or independent living facilities, and who are no longer appropriate candidates for hospital care. Despite the wide array of services and variety of needs addressed, SNFs are the lowest cost facility-based post-acute healthcare. As reimbursement and coverage continues to shift toward value-based models with

24

Table of Contents

greater emphasis on controlling costs, SNFs are integral to post-acute care and can continue to drive high-quality outcomes in low-cost settings.

Large, Fragmented Industry Comprised of Mostly Small and Independent Operators. According to the National Center for Health Statistics (NCHS) 2020 National Post-acute and Long-term Care Study, the SNF industry in the United States encompasses approximately 15,000 facilities and serves approximately 1.3 million patients annually. The industry is highly fragmented, with the top 10 operators, each having greater than approximately 100 facilities, representing approximately 12% of the total number of SNFs in the United States, according to CMS data as of September 2024, and approximately 5,000 smaller and independent operators of less than 100 facilities making up the remainder. According to such data, approximately 73% and 27% of SNFs are located in urban and rural areas, respectively. In addition, approximately 74%, 20%, and 6% of SNFs are operated as for-profit, non-profit, and by the government, respectively, according to such data. We believe this fragmented landscape creates opportunities for larger providers with greater scale to serve patients better and meet regulatory requirements nation-wide by effectively addressing staffing, quality standards, and billing processes. Moreover, many small and independent operators face pressure due to billing requirements, regulations, competition on quality of care and facilities, staffing shortages and competition, and the cessation of COVID-related provider relief funding, which has led them to pursue sales of their facilities or businesses. This provides additional opportunity for well-managed, high-quality operators to grow through acquisitions.

Growing Demand Outpacing Supply of Skilled Nursing Facilities. The demand for healthcare services in the United States has increased in recent years and is expected to continue growing, largely due to a rapidly aging population and an increasing prevalence of chronic conditions. While demand has increased for SNFs, the number of SNFs has declined in recent years from approximately 15,650 in 2017 to approximately 14,740 in 2025. We believe this is due to a variety of factors, including an inability of many facilities to comply with quality standards, rigorous staffing, and billing requirements, and a lack of technology and sophistication at small and independent operators. Furthermore, new operators face multiple barriers to entry, including the requirements to obtain a Certificate of Need, complex licensure requirements, lack of operating experience, and significant capital requirements. As a result, the addition of new SNFs has not kept pace with the number of SNFs exiting the market, amplifying the need for skilled nursing to serve an aging population.

Favorable Reimbursement Environment. According to CMS, approximately 72% of SNF revenue in 2022 was derived from government sources, including Medicare and Medicaid. Medicare represents 21% of industry revenue, while Medicaid represents 51%. The remainder comprises managed care, private pay, and other payors. Medicare and Medicaid reimbursement has steadily increased over the past few years. Medicare reimbursement per patient day increased at a CAGR of approximately 3.4% from 2012 to 2023, while Medicaid reimbursement per patient day increased at a CAGR of approximately 1.9% from 2012 to 2021. During that time, the industry experienced continued growth in reimbursement rates.

Regulatory Environment. The SNF industry is highly regulated with stringent regulatory compliance obligations. In the ordinary course of business, providers are subject to federal, state and local laws and regulations relating to, among other things, billing and reimbursement, relationships with vendors, business relationships with physicians and other healthcare providers and facilities, as well as licensure, accreditation, enrollment, quality, adequacy of care, physical plant, life safety, personnel, staffing and operating requirements. Changes in law or new interpretations of existing laws and regulations may have a significant impact on revenue, costs and business operations of providers and other industry participants. In addition, governmental and other authorities periodically inspect the SNFs, senior living facilities and outpatient rehabilitation agencies to verify continued compliance with applicable regulations and standards and may impose citations and other regulatory penalties for regulatory deficiencies. Such regulatory penalties include but are not limited to civil monetary penalties, temporary payment bans, suspension or revocation of a state operating license and loss of certification as a provider in the Medicare or Medicaid program, which may be temporary or permanent in nature. This regulatory environment and related enforcement can have an adverse effect on providers and other industry participants.

25

Table of Contents

Facility Information

The following table provides summary information regarding the location of our post-acute care facilities and operational beds by property type as of June 30, 2026:

[Excerpt truncated for page length; source filing is linked above.]

Latest 10-K MD&A (excerpt)

Latest 10-K Item 7 source: 0002001184-26-000005. The complete FY 2025 MD&A is published at /company/PACS/mda/fy2025/.

Extracted from a substantive MD&A body after the formal Item 7 span was a TOC or reference stub. Confidence: high. Filing date: 2026-02-27. Report date: 2025-12-31.

Overview

We are a leading post-acute healthcare company primarily focused on delivering high-quality skilled nursing care through a portfolio of independently operated facilities. Founded in 2013, we are one of the largest skilled nursing providers in the United States based on number of facilities. We also provide senior care, assisted living, and independent living options in some of our communities. As of December 31, 2025, our portfolio consisted of 321 post-acute care, assisted living, and independent living facilities across 17 states serving over 31,700 patients daily. We believe our significant historical growth has been primarily driven by our expertise in acquiring underperforming long-term custodial care skilled nursing facilities and transforming them into higher acuity, high value-add short-term transitional care skilled nursing facilities. We believe our success is driven in significant part by our locally led, centrally supported operating model, through which we empower local leaders at each facility to operate their facility autonomously and deliver excellence in clinical quality and a superior experience for our patients. We provide our independently operated facilities with a comprehensive suite of technology, support, and back-office services that enable local leadership teams to focus more of their time and effort on providing quality care to patients. We believe our operating model delivers value to all of our healthcare stakeholders, including patients and families, referring providers, payors, and administrators and clinicians.

We aim to create value by identifying and acquiring underperforming custodial care facilities and converting them into higher-value short-term transitional care facilities by investing in clinical teams and processes and upgrading technology, equipment, training, staffing, aesthetics, and other aspects of the business. We believe the resources and guidance offered by PACS Services are key to rapid integration of new facilities and provides our local leadership teams with an effective technology infrastructure, support tools, and regional support teams that enable local leadership to focus on operational improvements. Our facilities generally undergo an up to three-year post-acquisition transition period. During this period, we seek to implement best practices designed to realize and sustain the facility’s full potential. These practices often result in significant improvements to clinical quality and other operational metrics, including skilled mix, occupancy rates and payor contracting. We believe the results of our acquisition strategy are demonstrated by our high average QM Star rating and occupancy rate for Mature facilities of 4.4 and 95%, respectively, as of December 31, 2025. As of December 31, 2025, the average QM Star rating and occupancy rate for New facilities was 3.5 and 81%, respectively.

Material Weakness

As previously disclosed on our Annual Report on Form 10-K for the year ended December 31, 2024 as filed with the SEC on November 19, 2025, we identified material weaknesses in our internal control over financial reporting where we did not design and maintain sufficient processes to identify, assess, and communicate relevant risks to appropriate levels of the organization, including potential compliance issues received through the hotline process and we did not design and maintain adequate controls within the revenue process to appropriately recognize revenue for new services in accordance with Financial Accounting Standards Board Accounting Standards Codification Topic 606, Revenue from Contracts With Customers.

In addition, in connection with the preparation of our combined/consolidated financial statements for the year ended December 31, 2025, our management identified control deficiencies that, individually or in the aggregate, constitute material weaknesses in our internal control over financial reporting. The material weaknesses identified by management were that we did not design and maintain effective controls within the revenue process to address the completeness and accuracy of underlying data used to determine routine revenue. We also did not design controls to timely assess operational trends that could materially impact variable consideration estimates related to revenue recognition.

In addition, our Chief Executive Officer and our Interim Chief Financial Officer have concluded that, due to the material weaknesses, our disclosure controls and procedures were not effective, as such term is defined under Rules 13a-15(e) and 15(d)-15(e) under the Exchange Act, as of December 31, 2025. Management is committed to maintaining a strong internal control environment. In response to the identified material weaknesses above, management, with the oversight of the Audit Committee, is taking comprehensive actions to remediate the above material weaknesses. For additional information regarding the material weaknesses and our steps for remediation, please see “Part II, Item 9A, Controls and Procedures.”

Considering the material weaknesses described above, management performed additional analysis and other procedures to ensure that our combined/consolidated financial statements were prepared in accordance with U.S. generally accepted accounting principles (U.S. GAAP). Accordingly, management believes that the combined/consolidated financial statements included in this Annual Report on Form 10-K fairly present, in all material respects, our financial position, results of operations, and cash flows as of and for the periods presented, in accordance with U.S. GAAP.

74

Table of Contents

Key Skilled Services Metrics and Non-GAAP Financial Measures

We use the following key skilled services metrics and non-GAAP financial measures to help us evaluate our business, identify trends that affect our financial performance, and make strategic decisions.

Key Skilled Services Metrics

We monitor the below key skilled services metrics across all of our facilities and by Mature facilities, Ramping facilities, and New facilities. Mature facilities are defined as facilities purchased more than 36 months prior to a respective measurement date. Ramping facilities are defined as facilities purchased within 18 to 36 months prior to a respective measurement date. New facilities are defined as facilities purchased, or built, less than 18 months prior to a respective measurement date.

•Skilled nursing services revenue — Skilled nursing services revenue reflects the portion of patient and resident service revenue generated from all patients in skilled nursing facilities, excluding revenue generated from our assisted and independent living services.

•Skilled mix — We measure both revenue and nursing patient days by payor. Medicare and managed care patients, whom we refer to as high acuity patients, typically require a higher level of skilled nursing care. As a result, Medicare and managed care reimbursement rates are typically higher than those from other payors. In most states, Medicaid reimbursement rates are generally the lowest of all payor types. Changes in the payor mix can significantly affect our revenue and profitability. To monitor this performance, we evaluate two different measures of skilled mix:

◦Skilled mix by revenue — Skilled mix by revenue represents the portion of routine revenue generated from treating high acuity Medicare and managed care patients. Routine revenue refers to skilled nursing services revenue generated by contracted daily rates charged for skilled nursing services. Services provided outside of routine contractual agreements are recorded separately as ancillary revenue, including Medicare Part B therapy services, and are not routine revenue. The inclusion of therapy and other ancillary treatments in the contracted daily rate varies by payor source and by contract. Revenue associated with calculating skilled mix is based on contractually agreed-upon amounts or rates, excluding the estimates of variable consideration under the revenue recognition standard, Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) Topic 606, Revenue from Contracts with Customers (ASC 606).

◦Skilled mix by nursing patient days — Skilled mix by nursing patient days represents the number of days our high acuity Medicare and managed care patients receive skilled nursing services at skilled nursing facilities as a percentage of the total number of days that patients from all payor sources receive skilled nursing services at skilled nursing facilities for any given period.

•Occupancy — The total number of patients occupying a bed in a skilled nursing facility as a percentage of the beds in such facility that are available for occupancy during the period.

•Number of facilities — The total number of skilled nursing facilities that we operate. Excludes 30 and 27 assisted living and independent living facilities for the years ended December 31, 2025 and 2024, respectively.

•Number of operational beds — The total number of operational beds associated with the skilled nursing facilities that we own.

75

Table of Contents

The following tables present the above key skilled services metrics by category for all skilled nursing facilities, and for the skilled nursing facilities in each of the three facility cohorts, as of and for the years ended December 31, 2025 and 2024:

Year ended December 31,
20252024Change% Change
Total Facility Results(Dollars in thousands)
Skilled nursing services revenue$5,178,456$4,014,412$1,164,04429.0%
Skilled mix by revenue48.8%50.3%(1.5)%(3.0)%
Skilled mix by nursing patient days28.7%29.2%(0.5)%(1.7)%
Occupancy for skilled nursing services:
Available patient days11,836,8459,493,6392,343,20624.7%
Actual patient days10,541,4578,585,6541,955,80322.8%
Occupancy rate (operational beds)89.1%90.4%(1.3)%(1.4)%
Number of facilities at period end29128741.4%
Number of operational beds at period end32,85432,0168382.6%
Year ended December 31,
20252024Change% Change
Mature Facility Results(Dollars in thousands)
Skilled nursing services revenue$2,914,727$1,443,958$1,470,769101.9%
Skilled mix by revenue56.0%54.4%1.6%2.9%
Skilled mix by nursing patient days33.4%32.1%1.3%4.0%
Occupancy for skilled nursing services:
Available patient days5,748,8793,139,4412,609,43883.1%
Actual patient days5,457,7452,964,9092,492,83684.1%
Occupancy rate (operational beds)94.9%94.4%0.5%0.5%
Number of facilities at period end149137128.8%
Number of operational beds at period end16,41514,8931,52210.2%

[Excerpt truncated for page length; the complete text is on the linked full-MD&A page.]

Read the full FY 2025 MD&A or browse all MD&A years.

MD&A history

Prior-year 10-K MD&A spans are extracted from SEC filings with the same bounded parser used for the latest filing. Each year's full verbatim text is on its own sub-page.

Macro cross-references for PACS

Indicators mapped to this company's SIC classification (industry 8051 Services-Skilled Nursing Care Facilities) by grepcent's deterministic macro-sector crosswalk. A navigational mapping, not a statistical or causal claim.

Macro-to-micro threads including this sector: US labor market, Growth & output, Government finances, Sector employment.

All 71 macro indicators →

For LLMs & downloads

Markdown twin: /company/PACS.md · JSON record: /company/PACS.json · verified financials: JSON / CSV · machine TOC for the whole site: /llms.txt